These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3188458)

  • 1. [Effectiveness of antianginal preparations in ischemic heart disease depending on the duration of the courses of treatment].
    Progonnaia VV
    Vrach Delo; 1988 Jul; (7):29-31. PubMed ID: 3188458
    [No Abstract]   [Full Text] [Related]  

  • 2. [The efficacy of basic antianginal preparations in patients with stenocardia after the aortocoronary bypass operation].
    Vykhovaniuk IV
    Ter Arkh; 1991; 63(8):41-5. PubMed ID: 1792615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems in selecting the optimal propranolol dose in treating patients with angina pectoris of effort and the comparative effectiveness of inderal, anaprilin and obzidan].
    Romakov AIu; Mazur NA
    Ter Arkh; 1984; 56(9):41-6. PubMed ID: 6515546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
    Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of the anti-anginal effect of korinfar].
    Voronkov LG; Sokolov NF
    Farmakol Toksikol; 1988; 51(5):38-41. PubMed ID: 3208884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycerinated myocardiocyte fibers in the rat myocardium as one of the models in a preclinical assessment of antianginal agents].
    Dzhanpoladian EG; Sambelian VM; Kaĭfadzhian MA; Tatinian NG; Khoetsian EL
    Biull Eksp Biol Med; 1989 Apr; 107(4):444-6. PubMed ID: 2720162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
    Dunaev VV; Kraĭdashenko OV; Berezin AE
    Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary prevention and the rehabilitative therapy of patients with different forms of coronary pathology. The individual approach and criteria for determining efficacy].
    Karpov RS
    Ter Arkh; 1995; 67(8):34-6. PubMed ID: 7482330
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tolerance for the antianginal effect of nitrates. Approaches to its study].
    Martsevich SIu; Shakarova SSh; Metelitsa VI; Strel'tsov AA; Vygodin VA
    Ter Arkh; 1984; 56(9):46-50. PubMed ID: 6515547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
    Ermilov LP; Kuleshova EV; Treshkur TV; Andreeva IV
    Klin Med (Mosk); 1980 Apr; 58(4):77-81. PubMed ID: 6103973
    [No Abstract]   [Full Text] [Related]  

  • 14. [The significance of the ergometrine test for the diagnosis of ischemic heart disease and the choice of antianginal treatment].
    Voronkov LG; Remizovskiĭ GA
    Vrach Delo; 1991 Sep; (9):90-2. PubMed ID: 1759443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cordanum in the treatment of ischemic heart disease with stable extrasystole in the middle-aged and elderly].
    Korkushko OV; Butenko AG; Shatilo VB
    Sov Med; 1986; (8):3-8. PubMed ID: 2430340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment and prevention of ischemic heart disease].
    Ivanova TIu
    Feldsher Akush; 1983; 48(6):27-31. PubMed ID: 6557030
    [No Abstract]   [Full Text] [Related]  

  • 17. [How efficacy of antianginal drugs should be evaluated].
    Kośmicki M; Kowalik I; Sadowski Z
    Przegl Lek; 2000; 57(7-8):411-4. PubMed ID: 11109316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of isoptin on intrahepatic and central hemodynamics in ischemic heart disease].
    Komissarov VA
    Klin Med (Mosk); 1987 Sep; 65(9):64-7. PubMed ID: 3695314
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular drugs and exercise interactions.
    Kendrick ZV; Cristal N; Lowenthal DT
    Cardiol Clin; 1987 May; 5(2):227-44. PubMed ID: 3555797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.